Mangoceuticals
MGRX
5 hedge funds and large institutions have $166K invested in Mangoceuticals in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
3,030% more capital invested
Capital invested by funds: $5.32K → $166K (+$161K)
400% more funds holding
Funds holding: 1 → 5 (+4)
0.04% more ownership
Funds ownership: 0% → 0.04% (+0.04%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CRI
Colonial River Investments
Midlothian,
Virginia
|
+$47.4K |
| 2 |
Two Sigma Investments
New York
|
+$35.6K |
| 3 |
IAA
Independent Advisor Alliance
Charlotte,
North Carolina
|
+$34.2K |
| 4 |
PTC
Private Trust Company
Cleveland,
Ohio
|
+$1.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5.79K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CRI
1
Colonial River Investments
Midlothian,
Virginia
| $66.1K | +$47.4K | +2,407 | New |
|
|
2
Two Sigma Investments
New York
| $49.6K | +$35.6K | +1,807 | New |
|
|
IAA
3
Independent Advisor Alliance
Charlotte,
North Carolina
| $47.6K | +$34.2K | +1,733 | New |
|
|
PTC
4
Private Trust Company
Cleveland,
Ohio
| $2.75K | +$1.97K | +100 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $456 | -$5.79K | -294 | -95% |
|
MGRX Hedge Fund Activity: Q2 2023 in Review
5 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Mangoceuticals (MGRX) for Q2 2023, worth a combined $166K — up 3,030% from $5.32K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new MGRX positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Colonial River Investments, opening a new position worth an estimated $47.4K. The largest seller was UBS Group, cutting an estimated $5.79K.
- 5 institutional investors held Mangoceuticals (MGRX) as of Q2 2023, up from 1 in Q1 2023.
- Funds reported $166K of Mangoceuticals stock for Q2 2023, up 3,030% quarter-over-quarter.
- 4 funds opened new Mangoceuticals positions in Q2 2023 and 0 closed out, a net change of +4 holders.
- The largest Mangoceuticals buyer in Q2 2023 was Colonial River Investments, an estimated $47.4K added.
- The largest Mangoceuticals seller in Q2 2023 was UBS Group, an estimated $5.79K sold.
Based on aggregated 13F filings for Q2 2023.